MAML2
Basic information
Region (hg38): 11:95976598-96343195
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAML2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 57 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 57 | 1 | 1 |
Variants in MAML2
This is a list of pathogenic ClinVar variants found in the MAML2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-95979125-T-G | not specified | Uncertain significance (Aug 08, 2023) | ||
11-95979147-T-G | not specified | Uncertain significance (Dec 12, 2023) | ||
11-95979198-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
11-95979204-G-C | not specified | Uncertain significance (Nov 07, 2023) | ||
11-95979245-A-C | not specified | Uncertain significance (Nov 17, 2022) | ||
11-95979292-G-T | not specified | Uncertain significance (Jul 13, 2022) | ||
11-95979301-T-C | not specified | Uncertain significance (Oct 05, 2023) | ||
11-95979394-A-C | Uncertain significance (-) | |||
11-95979435-G-T | not specified | Uncertain significance (May 07, 2024) | ||
11-95979465-C-T | not specified | Uncertain significance (May 13, 2022) | ||
11-95979472-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
11-95979495-T-C | not specified | Uncertain significance (Oct 04, 2022) | ||
11-95979528-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
11-95979556-C-T | not specified | Uncertain significance (Feb 02, 2024) | ||
11-95979588-A-G | not specified | Uncertain significance (May 08, 2023) | ||
11-95979667-T-C | not specified | Uncertain significance (Apr 12, 2022) | ||
11-95979677-T-A | not specified | Uncertain significance (Apr 20, 2023) | ||
11-95979718-C-T | not specified | Uncertain significance (Sep 01, 2024) | ||
11-95979834-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
11-95979859-C-G | not specified | Uncertain significance (Apr 19, 2023) | ||
11-95979867-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
11-95979921-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
11-95979927-G-T | not specified | Uncertain significance (Sep 09, 2024) | ||
11-95985591-G-A | not specified | Uncertain significance (Nov 27, 2023) | ||
11-95985611-C-T | not specified | Uncertain significance (Jun 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAML2 | protein_coding | protein_coding | ENST00000524717 | 5 | 366583 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000131 | 124671 | 0 | 9 | 124680 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.450 | 584 | 615 | 0.949 | 0.0000309 | 7580 |
Missense in Polyphen | 97 | 95.577 | 1.0149 | 1123 | ||
Synonymous | -0.755 | 249 | 234 | 1.06 | 0.0000122 | 2261 |
Loss of Function | 5.91 | 6 | 51.9 | 0.116 | 0.00000273 | 487 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000647 | 0.0000619 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Potentiates activation by NOTCH3 and NOTCH4 more efficiently than MAML1 or MAML3. {ECO:0000269|PubMed:12370315, ECO:0000269|PubMed:12386158, ECO:0000269|PubMed:12539049}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving MAML2 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with CRTC1. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas. {ECO:0000269|PubMed:15729701}.;
- Pathway
- Th1 and Th2 cell differentiation - Homo sapiens (human);Notch signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);NOTCH-Ncore;Canonical and Non-canonical Notch signaling;Notch Signaling Pathway;Notch;Disease;RUNX3 regulates NOTCH signaling;Signal Transduction;Gene expression (Transcription);Transcriptional regulation by RUNX3;Generic Transcription Pathway;RNA Polymerase II Transcription;Notch-HLH transcription pathway;Notch;NICD traffics to nucleus;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH2;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH3;Signaling by NOTCH;TGF-beta super family signaling pathway canonical;Notch signaling pathway;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;BMP2 signaling TGF-beta MV;BMP signaling Dro;Notch-mediated HES/HEY network;Diseases of signal transduction;NOTCH1 Intracellular Domain Regulates Transcription
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- rvis_EVS
- 0.21
- rvis_percentile_EVS
- 67.52
Haploinsufficiency Scores
- pHI
- 0.287
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Maml2
- Phenotype
Gene ontology
- Biological process
- transcription initiation from RNA polymerase II promoter;Notch signaling pathway;positive regulation of transcription of Notch receptor target;positive regulation of Notch signaling pathway;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;nuclear speck
- Molecular function
- transcription coactivator activity